Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...
Paul P. Doghramji, MD, discusses the underdiagnosis of narcolepsy especially among younger individuals and how clinicians can address this.
The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. Matthew Horsnell began ...
TipRanks on MSN
Alkermes gains FDA breakthrough status for narcolepsy drug
The latest announcement is out from Alkermes ( (ALKS) ).
– Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1 – – Alixorexton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback